Nutritional Supplementation in Geriatric Hip Fractures

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorNYU Langone Health

About this trial

This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is:

\- Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?

Eligibility criteria

Qualifiers

Male or female, aged 65 years or older.

Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention.

Able to provide informed consent.

Expected to survive at least 6 months after surgery, with no terminal illness.

Disqualifiers

Pre-existing conditions that significantly impair mobility prior to injury.

Severe renal or liver impairment.

Active treatment with investigational drugs or participation in another clinical trial within the last 30 days.

Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders.

Trial design

Treatments tested in this trial

  • XR™ Recovery Supplement
  • XR Carbohydrate Loading Supplement

Treatment groups

118 Participants
are divided into 2 treatment groups

Sponsors and collaborators